AR008619A1 - Utilizacion de la flupirtina para la profilaxis y la terapia de enfermedades que se acompanan de una tasa de mortalidad celular mas alta que lafisiologia y medicamentos que comprenden flupirtina para dicha profilaxis y dicha terapia. - Google Patents
Utilizacion de la flupirtina para la profilaxis y la terapia de enfermedades que se acompanan de una tasa de mortalidad celular mas alta que lafisiologia y medicamentos que comprenden flupirtina para dicha profilaxis y dicha terapia.Info
- Publication number
- AR008619A1 AR008619A1 ARP970102797A ARP970102797A AR008619A1 AR 008619 A1 AR008619 A1 AR 008619A1 AR P970102797 A ARP970102797 A AR P970102797A AR P970102797 A ARP970102797 A AR P970102797A AR 008619 A1 AR008619 A1 AR 008619A1
- Authority
- AR
- Argentina
- Prior art keywords
- therapy
- flupirtine
- prophylaxis
- diseases
- accompanied
- Prior art date
Links
- JUUFBMODXQKSTD-UHFFFAOYSA-N N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester Chemical compound N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 JUUFBMODXQKSTD-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003667 flupirtine Drugs 0.000 title abstract 4
- 238000002560 therapeutic procedure Methods 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 238000011321 prophylaxis Methods 0.000 title abstract 3
- 230000035939 shock Effects 0.000 abstract 2
- 230000030833 cell death Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se trata de la utilizacion de la flupirtina o sus sales para la preparacion de un medicamento para la profilaxis y la terapia de enfermedades que estánacompanadas de una tasa de mortalidad celular más alta que la fisiologica. Particularmenteimp ortante es el tratamiento de afecciones orgánicas conprocesos citodestructivos, como infarto de miocardio, shock renal, shock pulmonar, maculodegeneracion senil o traumatismos debidos a influjos mecánicos,térmicos, por radiaciones otoxicos. T ambién se proponen medicamentos que contienen flupirtina para la terapia de las enfermedades mencionadas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19625582A DE19625582A1 (de) | 1996-06-27 | 1996-06-27 | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008619A1 true AR008619A1 (es) | 2000-02-09 |
Family
ID=7798082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102797A AR008619A1 (es) | 1996-06-27 | 1997-06-25 | Utilizacion de la flupirtina para la profilaxis y la terapia de enfermedades que se acompanan de una tasa de mortalidad celular mas alta que lafisiologia y medicamentos que comprenden flupirtina para dicha profilaxis y dicha terapia. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6124326A (es) |
| EP (1) | EP0912177B1 (es) |
| JP (1) | JP2000513346A (es) |
| AR (1) | AR008619A1 (es) |
| AT (1) | ATE258053T1 (es) |
| AU (1) | AU3340397A (es) |
| DE (2) | DE19625582A1 (es) |
| DK (1) | DK0912177T3 (es) |
| ES (1) | ES2213826T3 (es) |
| PT (1) | PT912177E (es) |
| WO (1) | WO1997049398A1 (es) |
| ZA (1) | ZA975306B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1353901A (en) * | 1999-12-01 | 2001-06-12 | Duke University | Method of treating batten disease |
| US6821995B1 (en) | 1999-12-01 | 2004-11-23 | Duke University | Method of treating batten disease |
| US6573083B1 (en) * | 2000-08-24 | 2003-06-03 | Stanley Raider | Method of weight reduction in human beings |
| DE10328260A1 (de) * | 2003-06-23 | 2005-01-27 | Schmidt, K.-G., Dr. med. | Flupirtine-Präparat |
| EP1688141A1 (en) * | 2005-01-31 | 2006-08-09 | elbion AG | The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
| DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4481205A (en) * | 1980-09-13 | 1984-11-06 | Degussa Aktiengesellschaft | 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate |
| US5336689A (en) * | 1990-03-02 | 1994-08-09 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| US5462965A (en) * | 1990-08-13 | 1995-10-31 | Gd Searle & Co. | Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases |
| DE4327516A1 (de) * | 1993-08-17 | 1995-02-23 | Asta Medica Ag | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
| DE19541405A1 (de) * | 1995-11-07 | 1997-05-15 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen |
-
1996
- 1996-06-27 DE DE19625582A patent/DE19625582A1/de not_active Withdrawn
-
1997
- 1997-06-11 US US08/873,124 patent/US6124326A/en not_active Expired - Lifetime
- 1997-06-17 ZA ZA9705306A patent/ZA975306B/xx unknown
- 1997-06-18 JP JP10502275A patent/JP2000513346A/ja active Pending
- 1997-06-18 PT PT97929212T patent/PT912177E/pt unknown
- 1997-06-18 DK DK97929212T patent/DK0912177T3/da active
- 1997-06-18 ES ES97929212T patent/ES2213826T3/es not_active Expired - Lifetime
- 1997-06-18 AT AT97929212T patent/ATE258053T1/de active
- 1997-06-18 EP EP97929212A patent/EP0912177B1/de not_active Expired - Lifetime
- 1997-06-18 DE DE59711240T patent/DE59711240D1/de not_active Expired - Lifetime
- 1997-06-18 AU AU33403/97A patent/AU3340397A/en not_active Abandoned
- 1997-06-18 WO PCT/EP1997/003179 patent/WO1997049398A1/de not_active Ceased
- 1997-06-25 AR ARP970102797A patent/AR008619A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997049398A1 (de) | 1997-12-31 |
| ES2213826T3 (es) | 2004-09-01 |
| AU3340397A (en) | 1998-01-14 |
| JP2000513346A (ja) | 2000-10-10 |
| ATE258053T1 (de) | 2004-02-15 |
| PT912177E (pt) | 2004-05-31 |
| DE59711240D1 (de) | 2004-02-26 |
| EP0912177B1 (de) | 2004-01-21 |
| ZA975306B (en) | 1998-01-05 |
| EP0912177A1 (de) | 1999-05-06 |
| DE19625582A1 (de) | 1998-01-02 |
| US6124326A (en) | 2000-09-26 |
| DK0912177T3 (da) | 2004-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2054995T3 (es) | Nuevos derivados del acido benzoico y acido fenilacetico, su obtencion y empleo como medicamentos. | |
| BR9912562A (pt) | Derivados de pirazol substituìdos condensados com anéis heterocìclicos com seis elementos | |
| ES2058291T3 (es) | Derivados de piperazinilo de las purinas e isosteros de las mismas como agentes hipoglucemicos. | |
| ES2020974B3 (es) | Medicamente conteniendo dipiridamol o mopidamol y o-acido acetilsalicilico o sus sales tratables fisiologicamente, procedimiento para su fabricacion y su utilizacion para combatir la formacion de trombos | |
| ES2017839A6 (es) | Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales> | |
| PT1162982E (pt) | Utilizacao de oligonucleotidos estabilizados pata a preparacao de um meicamento com accao anti-tumor | |
| AR010328A1 (es) | Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, procedimiento para su preparacion, medicamentos y su utilizacion para la fabricacion demedicamentos | |
| BR0114092A (pt) | Guanididas de ácido cinámico substituìdas, processos para a sua preparação, sua aplicação como medicamento bem como o medicamento contendo as mesmas | |
| PE20030738A1 (es) | Sales de acido succinico de 5,7,14-triazatetraciclo[10.3.1.02,11.04,9] -hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas | |
| ES8504838A1 (es) | Un procedimiento para preparar el antibiotico l 17046 | |
| Čičková et al. | Growth and survival of bagged Lucilia sericata maggots in wounds of patients undergoing maggot debridement therapy | |
| DE4394931T1 (de) | Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen | |
| PT82987B (pt) | Processo para a preparacao de novos de derivados de acidos carboxilicos bem como de composicoes farmaceuticas que os contem | |
| MX9200396A (es) | Derivados de benciloxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| AR008619A1 (es) | Utilizacion de la flupirtina para la profilaxis y la terapia de enfermedades que se acompanan de una tasa de mortalidad celular mas alta que lafisiologia y medicamentos que comprenden flupirtina para dicha profilaxis y dicha terapia. | |
| ES8303404A1 (es) | Procedimiento para preparar 3-amino-sidnoniminas sustituidas. | |
| ES8701738A1 (es) | Procedimiento para preparar nuevos 1,2,4-triazolo-carbamatos | |
| HN2003000015A (es) | Sales estables del acido o acetilsalicilico con aminoacidos basicos i i. | |
| ES8503676A1 (es) | Procedimiento de producir derivados de acido oxazolacetico | |
| ES2042523T3 (es) | Procedimiento para la preparacion de pirido-(2,3-b)(1,4)-benzodiazepin-6-onas. | |
| ES8502435A1 (es) | Un metodo para preparar 2(1h)-piridinonas | |
| AR015275A1 (es) | Bloque de lamer | |
| SCHAEFER et al. | Sodium gentisate in the treatment of acute rheumatic fever | |
| NO167459C (no) | Triazolforbindelser, deres anvendelse som fungicider, samt middel for kontroll av soppsykdommer i avlinger | |
| ES2146348T3 (es) | Cromanilsulfonil(tio)ureas sustituidas, procedimiento para su preparacion y su utilizacion en preparados farmaceuticos, asi como preparados farmaceuticos que las contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |